Entera Bio initiated by Leerink with $9 target, Outperform rating
Leerink Partners initiated coverage on Entera Bio Ltd. (ENTX) with an ‘Outperform’ rating and a $9 price target. ENTX closed at $3.03 per share on September 17, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.